Related references
Note: Only part of the references are listed.Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus
Victor A. Kostyuchenko et al.
JOURNAL OF VIROLOGY (2014)
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
Stephen J. Thomas et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
The Dengue Human Challenge Model: Has the Time Come to Accept This Challenge?
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C
Guntur Fibriansah et al.
JOURNAL OF VIROLOGY (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes
Nguyet Minh Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Dengue structure differs at the temperatures of its human and mosquito hosts
Xinzheng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identifying protective dengue vaccines: Guide to mastering an empirical process
Scott B. Halstead
VACCINE (2013)
Genetic and Phenotypic Characterization of Manufacturing Seeds for a Tetravalent Dengue Vaccine (DENVax)
Claire Y. -H. Huang et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Call to Action for Dengue Vaccine Failure
Suresh Mahalingam et al.
EMERGING INFECTIOUS DISEASES (2013)
Testing of Novel Dengue Virus 2 Vaccines in African Green Monkeys: Safety, Immunogenicity, and Efficacy
Katherine M. Smith et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Dengue vaccine development: a 75% solution?
Scott B. Halstead
LANCET (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
Ruklanthi de Alwis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric Yellow Fever 17D/Dengue viruses
Veronique Barban et al.
VIROLOGY (2012)
Lessons Learned during Dengue Outbreaks in the United States, 2001-2011
Amesh A. Adalja et al.
EMERGING INFECTIOUS DISEASES (2012)
Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age
R. Baxter et al.
VACCINE (2011)
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
John J. Treanor et al.
VACCINE (2011)
Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype
Katherine M. Smith et al.
VIROLOGY JOURNAL (2011)
Evolution of attenuating mutations in dengue-2 strain S16803 PDK50 vaccine and comparison of growth kinetics with parent virus
Eileen P. Kelly et al.
VIRUS GENES (2011)
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development
Anna P. Durbin et al.
VIRUSES-BASEL (2011)
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
Martina Beltramello et al.
CELL HOST & MICROBE (2010)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Inferring the Serotype Associated with Dengue Virus Infections on the Basis of Pre- and Postinfection Neutralizing Antibody Titers
Willem G. van Panhuis et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The Structure of Sindbis Virus Produced from Vertebrate and Invertebrate Hosts as Determined by Small-Angle Neutron Scattering
Lilin He et al.
JOURNAL OF VIROLOGY (2010)
Rationalizing the development of live attenuated virus vaccines
Adam S. Lauring et al.
NATURE BIOTECHNOLOGY (2010)
Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate
Eileen P. Kelly et al.
VACCINE (2010)
FluBlok, a next generation influenza vaccine manufactured in insect cells
Manon M. J. Cox et al.
BIOLOGICALS (2009)
Viremia and the Magnitude of the Immune Response upon Infection of Green Monkeys with Dengue Virus Type 2 Are Strain-Dependent
Jorge Martin et al.
CURRENT MICROBIOLOGY (2009)
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults
Wellington Sun et al.
HUMAN VACCINES (2009)
Viremia and antibody response in green monkeys (Chlorocebus aethiops sabaeus) infected with dengue virus type 2: A potential model for vaccine testing
Jorge Martin et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Dengue and hemorrhagic fever - A potential threat to public health in the United States
David M. Morens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells
D. Eugene Redmond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Protection of rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys:: a new model for the study of SIV pathogenesis in natural hosts
Ivona Pandrea et al.
JOURNAL OF VIROLOGY (2006)
Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys
Simoy Goldstein et al.
JOURNAL OF VIROLOGY (2006)
Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults
S Kitchener et al.
VACCINE (2006)
Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean Vervet
CA Lemere et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Deletions in the transmembrane domain of a Sindbis virus glycoprotein alter virus infectivity, stability, and host range
R Hernandez et al.
JOURNAL OF VIROLOGY (2003)
HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais
HAF Stephens et al.
TISSUE ANTIGENS (2002)
Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: Role of serotype concentration, ratio, and multiple doses
A Sabchareon et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
A single deletion in the membrane-proximal region of the Sindbis virus glycoprotein E2 endodomain blocks virus assembly
R Hernandez et al.
JOURNAL OF VIROLOGY (2000)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain
B Puri et al.
VIRUS GENES (2000)
Share Paper
